LexDanaLexDanabeta
Inventor

YAN-LING ZHANG

Inventor
US

Overview

4→
Patents
2022–2025
Patent span
Chemistry
Primary field (CPC C)

Patents· 4 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
C07DHeterocyclic compounds29%
A61KPreparations for medical, dental or toiletry purposes14%
C07CAcyclic or carbocyclic compounds14%
C07KPeptides14%
PatentTitleYear
12,428,373Dopamine D2 receptor ligands202511,572,368Inhibitors of histone deacetylase202311,498,896Dopamine D2 receptor ligands202211,377,423Inhibitors of histone deacetylase2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2025Patents assigned to BROAD INST INC (4)· patent assignee history
2022–2025Patents assigned to MASSACHUSETTS INST TECHNOLOGY (3)· patent assignee history
2022–2023Patents assigned to MASSACHUSETTS GEN HOSPITAL (2)· patent assignee history
2022–2025Based in US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
BROAD INST INC42022–2025
MASSACHUSETTS INST TECHNOLOGY32022–2025
MASSACHUSETTS GEN HOSPITAL22022–2023
Locations
LocationPatentsSpan
US42022–2025